(Q37140110)

18 August 2017

Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation (English)

1 reference

18 August 2017

endometrial carcinoma

1 reference

A Dutt

4

0 references

Inge Jonassen

object named as

I Jonassen

14

0 references

Lars A. Akslen

22

object named as

L A Akslen

1 reference

18 August 2017

10

J Trovik

1 reference

18 August 2017

5

G Getz

1 reference

18 August 2017

12

H Greulich

1 reference

18 August 2017

17

L A Garraway

1 reference

18 August 2017

23

R Beroukhim

1 reference

18 August 2017

H B Salvesen

1

1 reference

18 August 2017

S L Carter

2

1 reference

18 August 2017

M Mannelqvist

3

1 reference

18 August 2017

I M Stefansson

6

1 reference

18 August 2017

M B Raeder

7

1 reference

18 August 2017

M L Sos

8

1 reference

18 August 2017

I B Engelsen

9

1 reference

18 August 2017

E Wik

11

1 reference

18 August 2017

T H Bø

13

1 reference

18 August 2017

R K Thomas

15

1 reference

18 August 2017

T Zander

16

1 reference

18 August 2017

A M Oyan

18

1 reference

18 August 2017

W R Sellers

19

1 reference

18 August 2017

K H Kalland

20

1 reference

18 August 2017

M Meyerson

21

1 reference

18 August 2017

language of work or name

English

0 references

publication date

4 March 2009

1 reference

Proceedings of the National Academy of Sciences of the United States of America

18 August 2017

1 reference

18 August 2017

106

1 reference

18 August 2017

12

1 reference

18 August 2017

4834-4839

1 reference

Drug-sensitive FGFR2 mutations in endometrial carcinoma

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

Genomic signatures to guide the use of chemotherapeutics.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

Summaries of Affymetrix GeneChip probe level data

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

Carcinoma of the endometrium in Norway: a histopathological and prognostic survey of a total population

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

Significance analysis of microarrays applied to the ionizing radiation response

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

PIK3CA gene mutations and amplifications in uterine cancers, identified by methods that avoid confounding by PIK3CA pseudogene sequences

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

Exploring the specificity of the PI3K family inhibitor LY294002.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

PTEN/MMAC1 mutations in endometrial cancers

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

PIK3CA is implicated as an oncogene in ovarian cancer.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2660768

The Molecular Biology Database Collection: 2003 update

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.0806514106

Patterns ofPIK3CA alterations in familial colorectal and endometrial carcinoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.0806514106

Genomic aberrations in carcinomas of the uterine corpus

21 January 2018

1 reference

12 December 2020

Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression

1 reference

12 December 2020

1 reference

12 December 2020

Chromosomal alterations in 98 endometrioid adenocarcinomas analyzed with comparative genomic hybridization

1 reference

12 December 2020

Endometrial carcinoma

1 reference

12 December 2020

PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters

1 reference

12 December 2020

Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.0806514106

1 reference

OpenCitations bibliographic resource ID

18 August 2017

0 references

0 references

1 reference

18 August 2017

PubMed publication ID

19261849

1 reference